Home › Asset managers › Compare 2024-2025 › Fidelity vs Lincoln Financial
Fidelity 2024-2025 · Lincoln Financial 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 74,342 | 65,321 | 2,324 | 6,697 | 96.6% | 93.2% |
| Board proposals | 60,945 | 53,132 | 2,069 | 5,744 | 96.3% | 92.7% |
| E&S shareholder proposals | 270 | 135 | 4 | 131 | 97.1% | 85.8% |
| Other items | 13,127 | 12,054 | 251 | 822 | 98.0% | 95.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
9,021 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Fidelity | Lincoln Financial |
|---|---|---|---|---|---|---|
| CROWDSTRIKE HOLDINGS INC. | June 18, 2025 | To elect CrowdStrike's nominees Cary J. Davis, George Kurtz and Laura J. Schumacher to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Cary J. Davis Director Elections |
Board | For | FOR 37 funds |
WITHHOLD 2 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Attribution of Profit and Loss During the Transition Period Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Audit Report, Pro Forma Review Report and Valuation Report in Relation to the Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds Capital Structure |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) Extraordinary Transactions |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | April 15, 2025 | Approve Use of Idle Raised Funds and Own Funds for Cash Management Extraordinary Transactions |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Andrew W. Hobson Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Brian G. Kushner Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Deborah A. Farrington Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Joan Hogan Gillman Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Mary G. Berner Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Thomas H. Castro Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Proposal to approve, on an advisory basis, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| CUSTOM TRU | June 12, 2025 | To elect each of the four Class C directors to serve until the 2028 annual meeting of stockholders and until his or her successor is duly elected and qualified: Fred Ross Director Elections |
Board | Not determined | FOR 12 funds |
WITHHOLD 2 funds |
| CUTERA INC. | July 15, 2024 | Approval of the amendment and restatement of our 2019 Equity Incentive Plan to increase the total shares available for issuance under the 2019 Equity Incentive Plan by 2,395,275 shares. Compensation |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CUTERA INC. | July 15, 2024 | Approval of the amendment of outstanding stock options to reduce the exercise price per share to the closing price on the date of the Annual Meeting. Compensation |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CUTERA INC. | July 15, 2024 | Election of Directors: Jeryl Hilleman Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CUTERA INC. | July 15, 2024 | Election of Directors: Keith Sullivan Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CUTERA INC. | July 15, 2024 | Election of Directors: Kevin Cameron Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CVS GROUP PLC | November 20, 2024 | Approve Remuneration Report Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| D'AMICO INTERNATIONAL SHIPPING SA | April 29, 2025 | Approve DIS 2025-2027 Medium-Long Term Variable Incentive Plan Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| D'IETEREN GROUP | December 6, 2024 | Approve Dividends Capital Structure |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| DANIELI & C. OFFICINE MECCANICHE SPA | October 25, 2024 | Authorize Share Repurchase Program and Reissuance of Repurchased Shares Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DANIMER SCIENTIFIC INC. | July 9, 2024 | Election of Directors: John P. Amboian Director Elections |
Board | For | FOR 10 funds |
WITHHOLD 1 fund |
| DATANG INTERNATIONAL POWER GENERATION CO. LTD. | December 31, 2024 | Approve Financing Proposal of Datang International as the Parent Company for the Year of 2025 Capital Structure |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Authorize Board to Repurchase Shares Capital Structure |
Board | For | FOR 22 funds |
AGAINST 1 fund |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Reelect Alessandra Garavoglia as Non-Executive Director Director Elections |
Board | For | FOR 22 funds |
AGAINST 1 fund |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Reelect Fabio Di Fede as Executive Director Director Elections |
Board | For | FOR 22 funds |
AGAINST 1 fund |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Reelect Luca Garavoglia as Non-Executive Director Director Elections |
Board | For | FOR 22 funds |
AGAINST 1 fund |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Reelect Paolo Marchesini as Executive Director Director Elections |
Board | For | FOR 22 funds |
AGAINST 1 fund |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Reelect Robert Kunze-Concewitz as Non-Executive Director Director Elections |
Board | For | FOR 22 funds |
AGAINST 1 fund |
| DAY ONE BIOPHARMACEUTICALS INC. | June 2, 2025 | Election of Class I Directors: Garry Nicholson Director Elections |
Board | For | FOR 36 funds |
WITHHOLD 4 funds |
| DEFINITIVE HEALTHCARE CORP. | June 5, 2025 | To elect the three Class I directors of Definitive Healthcare Corp. named below, each to serve a three-year term expiring at the 2028 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Kevin Coop Director Elections |
Board | For | FOR 10 funds |
WITHHOLD 2 funds |
| DELEK AUTOMOTIVE SYSTEMS LTD. | July 8, 2024 | Approve Amended Compensation Policy for the Directors and Officers of the Company Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DELFI LTD. | April 29, 2025 | Approve Issuance of Equity or Equity-Linked Securities with or without Preemptive Rights Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| DELIVERY HERO SE | June 18, 2025 | Approve Creation of EUR 10 Million Pool of Authorized Capital 2025/IV with or without Exclusion of Preemptive Rights Capital Structure |
Board | For | FOR 12 funds |
AGAINST 1 fund |
| DEMANT A/S | March 6, 2025 | APPROVE REMUNERATION REPORT (ADVISORY VOTE) Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| DERICHEBOURG SA | January 29, 2025 | Approve Compensation of Abderrahmane El Aoufir, CEO Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| DERICHEBOURG SA | January 29, 2025 | Approve Compensation of Thomas Derichebourg, Vice-CEO Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| DERICHEBOURG SA | January 29, 2025 | Reelect Catherine Claverie as Director Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| DESIGN THERAPEUTICS INC. | June 10, 2025 | To elect the three nominees for Class I director named herein to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Heather Berger, Ph.D. Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 1 fund |
| DEUTSCHE LUFTHANSA AG | May 6, 2025 | Elect Angela Titzrath to the Supervisory Board Director Elections |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| DHI GROUP INC. | May 16, 2025 | Advisory vote with respect to the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| DIASORIN SPA | April 28, 2025 | Approve Long-Term Incentive Plan Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| DIASORIN SPA | April 28, 2025 | Approve Stock Option Plan Compensation |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| DICK'S SPORTING GOODS INC. | June 11, 2025 | Election of Directors for a term that expires in 2026: Anne Fink Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| DICKER DATA LTD. | May 21, 2025 | Elect Leanne Ralph as Director Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| DIRECT LINE INSURANCE GROUP PLC | May 14, 2025 | Approve Remuneration Report Compensation |
Board | For | FOR 10 funds |
AGAINST 1 fund |
| DIXON TECHNOLOGIES (INDIA) LTD. | September 25, 2024 | Approve Enhancement of the Limits of Inter-corporate Loans, Investments, Guarantee or Security and Acquisition Capital Structure |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| DMC GLOBAL INC. | May 14, 2025 | Election of Directors: Ouma Sananikone Director Elections |
Board | For | FOR 12 funds |
WITHHOLD 3 funds |
| DONG-E-E-JIAO CO. LTD. | May 20, 2025 | Approve Investment in Financial Products Extraordinary Transactions |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| DOOSAN BOBCAT INC. | March 26, 2025 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | FOR 10 funds |
AGAINST 1 fund |
| DOOSAN ENERBILITY CO. LTD. | March 31, 2025 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | FOR 9 funds |
AGAINST 1 fund |
| DOUGLAS ELLIMAN INC. | June 25, 2025 | Advisory vote on executive compensation (the "say-on-pay" vote): Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 2 funds |
| DOUGLAS ELLIMAN INC. | June 25, 2025 | Election of Directors: Richard J. Lampen Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 2 funds |
| DOVALUE SPA | September 11, 2024 | Approve Increase in the Remuneration of Directors Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DOVALUE SPA | April 29, 2025 | Approve Adjustment of the Performance Targets for the Cycles of the LTIP 2022-2024 Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DOVALUE SPA | April 29, 2025 | Approve Remuneration Policy Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DOVALUE SPA | April 29, 2025 | Approve Second Section of the Remuneration Report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DRAFTKINGS INC. | May 19, 2025 | Election of Directors: Valerie Mosley Director Elections |
Board | For | FOR 42 funds |
WITHHOLD 4 funds |
| DRAFTKINGS INC. | May 19, 2025 | Election of Directors: Woodrow H. Levin Director Elections |
Board | For | FOR 42 funds |
WITHHOLD 4 funds |
| DREAM FINDERS HOMES INC. | June 9, 2025 | Election of Directors: Leonard M. Sturm Director Elections |
Board | For | FOR 11 funds |
AGAINST 3 funds |
| DSM-FIRMENICH AG | May 6, 2025 | REELECT PATRICK FIRMENICH AS DIRECTOR Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| DULUTH HOLDINGS INC. | May 29, 2025 | Election of Directors: Brett L. Paschke Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 2 funds |
| DULUTH HOLDINGS INC. | May 29, 2025 | Election of Directors: Ronald Robinson Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 2 funds |
| DULUTH HOLDINGS INC. | May 29, 2025 | Election of Directors: Scott K. Williams Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 2 funds |
| DULUTH HOLDINGS INC. | May 29, 2025 | To approve, by an advisory vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| DWS GROUP GMBH & CO. KGAA | June 13, 2025 | Approve Remuneration Policy Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| DWS GROUP GMBH & CO. KGAA | June 13, 2025 | Approve Remuneration Report Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| DYE & DURHAM LTD. | December 17, 2024 | Approve Stock Option Plan Grants Compensation |
Board | Contested | FOR 3 funds |
AGAINST 1 fund |
← Previous Page 8 of 91 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.